Trim33/Tif1γ is involved in late stages of granulomonopoiesis in mice

Experimental Hematology

Volumn 44, Issue 8, 2016, Pages 727-739.e6

  Chrétien, Marie Lorraine ^a,b   Legouge, Caroline ^a,b   Martin, Romain Z ^a   Hammann, Arlette ^a   Trad, Malika ^a   Aucagne, Romain ^a   Largeot, Anne ^a   Bastie, Jean Noël ^a,b   Delva, Laurent ^a   Quéré, Ronan ^a  

^a UNIVERSITÉ BOURGOGNE FRANCHE COMTÉ   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; COLONY STIMULATING FACTOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTIONAL INTERMEDIARY FACTOR 1 GAMMA; TRANSFORMING GROWTH FACTOR BETA; TRIPARTITE MOTIF PROTEIN 33; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; TRIM33 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL EXPANSION; CELL MATURATION; CONTROLLED STUDY; GRANULOCYTE; GRANULOPOIESIS; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; ANIMAL; APOPTOSIS; CELL LINEAGE; CELL MOTION; COLONY FORMING UNIT GM; CYTOLOGY; DISEASE MODEL; GENETICS; IMMUNOPHENOTYPING; KNOCKOUT MOUSE; METABOLISM; MYELOPOIESIS; MYELOPROLIFERATIVE DISORDER; PATHOLOGY; PHENOTYPE;

ANIMALS; APOPTOSIS; BIOMARKERS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELL MOVEMENT; DISEASE MODELS, ANIMAL; GRANULOCYTE-MACROPHAGE PROGENITOR CELLS; IMMUNOPHENOTYPING; MICE; MICE, KNOCKOUT; MYELOID CELLS; MYELOPOIESIS; MYELOPROLIFERATIVE DISORDERS; PHENOTYPE; TRANSCRIPTION FACTORS;

EID: 84979688605     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2016.04.009     Document Type: Article

References (43)

1. 1 Venturini, L., You, J., Stadler, M., et al. TIF1gamma, a novel member of the transcriptional intermediary factor 1 family. Oncogene 18 (1999), 1209–1217.
2. 2 Yan, K.P., Dolle, P., Mark, M., et al. Molecular cloning, genomic structure, and expression analysis of the mouse transcriptional intermediary factor 1 gamma gene. Gene 334 (2004), 3–13.
3. 3 Hatakeyama, S., TRIM proteins and cancer. Nat Rev Cancer 11 (2011), 792–804.
4. 4 Xue, J., Chen, Y., Wu, Y., et al. Tumour suppressor TRIM33 targets nuclear β-catenin degradation. Nat Commun, 6, 2015, 6156.
5. 5 Vincent, D.F., Yan, K.P., Treilleux, I., et al. Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas. PLoS Genet, 5, 2009, e1000575.
6. 6 Herquel, B., Ouararhni, K., Khetchoumian, K., et al. Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma. Proc Natl Acad Sci U S A 108 (2011), 8212–8217.
7. 7 Ding, Z.I., Jin, G.N., Wang, W., et al. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Hepatology 60 (2014), 1620–1636.
8. 8 Li, H., Wawrose, J.S., Gooding, W.E., et al. Genomic analysis of head and neck squamous cell carcinoma cell lines and human tumors: A rational approach to preclinical model selection. Mol Cancer Res 12 (2014), 571–582.
9. 9 Wang, L., Lei, Z., Liu, X., Liu, R., Zhang, H., Association of mutation and methylation in the promoter region of TIF1γ with non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 16 (2013), 227–232.
10. 10 Jingushi, K., Ueda, Y., Kitae, K., et al. miR-629 Targets TRIM33 to promote TGFβ/Smad signaling and metastatic phenotypes in ccRCC. Mol Cancer Res 13 (2015), 565–574.
11. 11 Kulkarni, A., Oza, J., Yao, M., et al. Tripartite motif-containing 33 (TRIM33) functions in the Poly(ADP-ribose)polymerase (PARP)-dependent DNA damage response through interaction with Amplified in Liver Cancer-1 (ALC1). J Biol Chem 288 (2013), 32357–32369.
12. 12 Jain, S., Singhal, S., Francis, F., et al. Association of overexpression of TIF1gamma with colorectal carcinogenesis and advanced colorectal adenocarcinoma. World J Gastroenterol 17 (2011), 3994–4000.
13. 13 Quéré, R., Saint-Paul, L., Carmignac, V., et al. Tif1γ regulates the TGF-β1 receptor and promotes physiological aging of hematopoietic stem cells. Proc Natl Acad Sci U S A 111 (2014), 10592–10597.
14. 14 Aucagne, R., Droin, N., Paggetti, J., et al. Transcription intermediary factor 1gamma is a tumor suppressor in mouse and human chronic myelomonocytic leukemia. J Clin Invest 121 (2011), 2361–2370.
15. 15 He, W., Dorn, D.C., Erdjument-Bromage, H., Tempst, P., Moore, M.A., Massagué, J., Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell 125 (2006), 929–941.
16. 16 Ransom, D.G., Bahary, N., Niss, K., et al. The zebrafish moonshine gene encodes transcriptional intermediary factor 1gamma, an essential regulator of hematopoiesis. PLoS Biol, 2, 2004, E237.
17. 17 Kusy, S., Gault, N., Ferri, F., et al. Adult hematopoiesis is regulated by TIF1gamma, a repressor of TAL1 and PU.1 transcriptional activity. Cell Stem Cell 8 (2011), 412–425.
18. 18 Bai, X., Kim, J., Yang, Z., et al. TIF1gamma controls erythroid cell fate by regulating transcription elongation. Cell 142 (2010), 133–143.
19. 19 Bai, X., Trowbridge, J.J., Riley, E., et al. TiF1-gamma plays an essential role in murine hematopoiesis and regulates transcriptional elongation of erythroid genes. Dev Biol 373 (2013), 422–430.
20. 20 Xi, Q., Wang, Z., Zaromytidou, A.I., et al. A poised chromatin platform for TGF-beta access to master regulators. Cell 147 (2011), 1511–1524.
21. 21 Dupont, S., Zacchigna, L., Cordenonsi, M., et al. Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell 121 (2005), 87–99.
22. 22 Dupont, S., Mamidi, A., Cordenonsi, M., et al. FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination. Cell 136 (2009), 123–135.
23. 23 Morsut, L., Yan, K.P., Enzo, E., et al. Negative control of Smad activity by ectodermin/Tif1gamma patterns the mammalian embryo. Development 137 (2010), 2571–2578.
24. 24 Agricola, E., Randall, R.A., Gaarenstroom, T., Dupont, S., Hill, C.S., Recruitment of TIF1gamma to chromatin via its PHD finger-bromodomain activates its ubiquitin ligase and transcriptional repressor activities. Mol Cell 43 (2011), 85–96.
25. 25 Fattet, L., Ay, A.S., Bonneau, B., et al. TIF1gamma requires sumoylation to exert its repressive activity on TGFbeta signaling. J Cell Sci 126 (2013), 3713–3723.
26. 26 Hesling, C., Fattet, L., Teyre, G., et al. Antagonistic regulation of EMT by TIF1gamma and Smad4 in mammary epithelial cells. EMBO Rep 12 (2011), 665–672.
27. 27 Hesling, C., Lopez, J., Fattet, L., et al. Tif1gamma is essential for the terminal differentiation of mammary alveolar epithelial cells and for lactation through SMAD4 inhibition. Development 140 (2013), 167–175.
28. 28 Gabrilovich, D.I., Ostrand-Rosenberg, S., Bronte, V., Coordinated regulation of myeloid cells by tumours. Nature Rev Immunol 12 (2012), 253–268.
29. 29 Movahedi, K., Guilliams, M., Van den Bossche, J., et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111 (2008), 4233–4244.
30. 30 Youn, J.I., Nagaraj, S., Collazo, M., Gabrilovich, D.I., Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 181 (2008), 5791–5802.
31. 31 Kusmartsev, S., Gabrilovich, D.I., Inhibition of myeloid cell differentiation in cancer: The role of reactive oxygen species. J Leukoc Biol 74 (2003), 186–196.
32. 32 Diaz-Montero, C.M., Salem, M.L., Nishimura, M.I., Garrett-Mayer, E., Cole, D.J., Montero, A.J., Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother 58 (2009), 49–59.
33. 33 Gabrilovich, D.I., Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system. Nature Rev Immunol 9 (2009), 162–174.
34. 34 Cheng, P., Corzo, C.A., Luetteke, N., et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 205 (2008), 2235–2249.
35. 35 Sinha, P., Okoro, C., Foell, D., Freeze, H.H., Ostrand-Rosenberg, S., Srikrishna, G., Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol 181 (2008), 4666–4675.
36. 36 Vasquez-Dunddel, D., Pan, F., Zeng, Q., et al. STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients. J Clin Invest 123 (2013), 1580–1589.
37. 37 Jayaraman, P., Parikh, F., Lopez-Rivera, E., et al. Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release. J Immunol 188 (2012), 5365–5376.
38. 38 Youn, J.I., Gabrilovich, D.I., The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 40 (2010), 2969–2975.
39. 39 Peroni, A., Colato, C., Schena, D., Rongioletti, F., Girolomoni, G., Histiocytoid Sweet syndrome is infiltrated predominantly by M2-like macrophages. J Am Acad Dermatol 72 (2015), 131–139.
40. 40 Magro, C.M., Momtahen, S., Nguyen, G.H., Wang, X., Histiocytoid Sweet's Syndrome: A localized cutaneous proliferation of macrophages frequently associated with chronic myeloproliferative disease. Eur J Dermatol 25 (2015), 335–341.
41. 41 Gordon, S., Plüddemann, A., Martinez Estrada, F., Macrophage heterogeneity in tissues: Phenotypic diversity and functions. Immunol Rev 262 (2014), 36–55.
42. 42 Weng, L., Mitoma, H., Trichot, C., et al. The E3 ubiquitin ligase tripartite motif 33 is essential for cytosolic RNA-induced NLRP3 inflammasome activation. J Immunol 193 (2014), 3676–3682.
43. 43 Ferri, F., Parcelier, A., Petit, V., et al. TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activation. Nat Commun, 6, 2015, 8900.